Appointment of Shore Capital as Nominated Adviser & Sole Broker

October 3, 2016

IXICO plc (AIM: IXI), the brain health company, announces the appointment of Shore Capital and Corporate Limited as Nominated Adviser and Shore Capital Stockbrokers Limited as sole Broker, (together "Shore Capital"), with immediate effect.

Download full press release here

For further information please contact: 

IXICO plc 
Derek Hill, Chief Executive Officer 
Susan Lowther, Chief Financial Officer    

Tel: +44 20 3763 7499

Shore Capital (Nomad and Broker)
Bidhi Bhoma / Edward Mansfield    

Tel: +44 20 7408 4090

FTI Consulting Limited (Investor Relations)
Simon Conway/Mo Noonan/Matthew Moss    

Tel: +44 20 3727 1000


IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions.  In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes.  In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.

The Company's brain health focus includes Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, behavioural health, child and adolescent mental health.

More information is available on